DESVENLAFAXINE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 5 adverse event reports in the FDA FAERS database where DESVENLAFAXINE was used for Psoriasis.
Most Reported Side Effects for DESVENLAFAXINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,576 | 17.7% | 3 | 79 |
| Anxiety | 679 | 7.6% | 4 | 60 |
| Feeling abnormal | 671 | 7.5% | 0 | 55 |
| Dizziness | 605 | 6.8% | 3 | 56 |
| Nausea | 575 | 6.4% | 4 | 57 |
| Headache | 548 | 6.1% | 3 | 60 |
| Depression | 542 | 6.1% | 8 | 66 |
| Withdrawal syndrome | 530 | 5.9% | 1 | 56 |
| Malaise | 512 | 5.7% | 1 | 55 |
| Insomnia | 428 | 4.8% | 2 | 44 |
| Off label use | 420 | 4.7% | 5 | 75 |
| Suicidal ideation | 408 | 4.6% | 2 | 74 |
| Fatigue | 342 | 3.8% | 1 | 33 |
| Drug withdrawal syndrome | 322 | 3.6% | 1 | 24 |
| Crying | 310 | 3.5% | 0 | 36 |
Other Indications for DESVENLAFAXINE
Depression (2,714)
Anxiety (989)
Product used for unknown indication (989)
Major depression (485)
Bipolar disorder (158)
Post-traumatic stress disorder (102)
Generalised anxiety disorder (76)
Obsessive-compulsive disorder (65)
Antidepressant therapy (52)
Panic attack (45)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)